二甲双胍
医学
安普克
骨关节炎
机制(生物学)
药品
2型糖尿病
作用机理
糖尿病
生物信息学
药理学
内科学
内分泌学
生物
病理
磷酸化
哲学
替代医学
体外
认识论
蛋白激酶A
生物化学
作者
Miao He,Bangbao Lu,Michael Opoku,Liang Zhang,Wenqing Xie,Hongfu Jin,Siyu Chen,Yusheng Li,Zhenhan Deng
出处
期刊:Cells
[Multidisciplinary Digital Publishing Institute]
日期:2022-09-27
卷期号:11 (19): 3012-3012
被引量:36
标识
DOI:10.3390/cells11193012
摘要
For over 60 years, metformin has been widely prescribed by physicians to treat type 2 diabetes. Along with more in-depth research on metformin and its molecular mechanism in recent decades, metformin has also been proposed as an effective drug to prevent or delay musculoskeletal disorders, including osteoarthritis (OA). The occurrence and development of OA are deemed to be associated with the impaired mitochondrial functions of articular chondrocytes. Metformin can activate the pathways and expressions of both AMPK and SIRT1 so as to protect the mitochondrial function of chondrocytes, thereby promoting osteoblast production. Moreover, the clinical significance of the metformin combination therapy in preventing OA has also been demonstrated. This review aimed to comprehensively summarize the current research progress on metformin as a proposed drug for OA prevention or treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI